Asenapine as the first aid in Psychiatry

抄録

Asenapine is approved in Japan as monotherapy and first aid in adults with Schizophrenia. This is the first study to evaluate the gender distinction in the efficacy. I determined and compared the reduction of severity in Schizophrenia using with PANSS especially in males and females. The result indicate that Asenapine has a unique improvement in gender difference in statistical assessment. I would like to do the presentation for you with some consideration.